A listing of human tumor antigens recognized by T cells: March 2004 update

Luisa Novellino, Chiara Castelli, Giorgio Parmiani

Research output: Contribution to journalArticle

364 Citations (Scopus)

Abstract

The technological advances occurred in the last few years have led to a great increase in the number of tumor associated antigens (TAA) that are currently available for clinical applications. In this review we provide a comprehensive list of human tumor antigens as reported in the literature updated at Feburary 2004. The list includes all T cell-defined epitopes, while excluding analogs or artificially modified epitopes, as well as virus-encoded and antibodies-recognized antigens. TAAs are listed in alphabetical order along with the epitope sequence and the HLA allele which restricts recognition by T cells. Data on the tissue distribution of each antigen are also provided together with an extensive bibliography that allows a rapid search for any additional information may be needed on each single antigen or epitope. Overall, the updated list is a database tool for clinicians, scientists and students who have an interest in the field of tumor immunology and immunotherapy.

Original languageEnglish
Pages (from-to)187-207
Number of pages21
JournalCancer Immunology, Immunotherapy
Volume54
Issue number3
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Neoplasm Antigens
Epitopes
T-Lymphocytes
Antigens
T-Lymphocyte Epitopes
Bibliography
Tissue Distribution
Allergy and Immunology
Immunotherapy
Alleles
Databases
Students
Viruses
Antibodies
Neoplasms

Keywords

  • Antigens
  • Epitopes
  • T cells
  • Tumor

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Cite this

A listing of human tumor antigens recognized by T cells : March 2004 update. / Novellino, Luisa; Castelli, Chiara; Parmiani, Giorgio.

In: Cancer Immunology, Immunotherapy, Vol. 54, No. 3, 03.2005, p. 187-207.

Research output: Contribution to journalArticle

@article{c15a4203c2144665849196d3406de1ec,
title = "A listing of human tumor antigens recognized by T cells: March 2004 update",
abstract = "The technological advances occurred in the last few years have led to a great increase in the number of tumor associated antigens (TAA) that are currently available for clinical applications. In this review we provide a comprehensive list of human tumor antigens as reported in the literature updated at Feburary 2004. The list includes all T cell-defined epitopes, while excluding analogs or artificially modified epitopes, as well as virus-encoded and antibodies-recognized antigens. TAAs are listed in alphabetical order along with the epitope sequence and the HLA allele which restricts recognition by T cells. Data on the tissue distribution of each antigen are also provided together with an extensive bibliography that allows a rapid search for any additional information may be needed on each single antigen or epitope. Overall, the updated list is a database tool for clinicians, scientists and students who have an interest in the field of tumor immunology and immunotherapy.",
keywords = "Antigens, Epitopes, T cells, Tumor",
author = "Luisa Novellino and Chiara Castelli and Giorgio Parmiani",
year = "2005",
month = "3",
doi = "10.1007/s00262-004-0560-6",
language = "English",
volume = "54",
pages = "187--207",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "3",

}

TY - JOUR

T1 - A listing of human tumor antigens recognized by T cells

T2 - March 2004 update

AU - Novellino, Luisa

AU - Castelli, Chiara

AU - Parmiani, Giorgio

PY - 2005/3

Y1 - 2005/3

N2 - The technological advances occurred in the last few years have led to a great increase in the number of tumor associated antigens (TAA) that are currently available for clinical applications. In this review we provide a comprehensive list of human tumor antigens as reported in the literature updated at Feburary 2004. The list includes all T cell-defined epitopes, while excluding analogs or artificially modified epitopes, as well as virus-encoded and antibodies-recognized antigens. TAAs are listed in alphabetical order along with the epitope sequence and the HLA allele which restricts recognition by T cells. Data on the tissue distribution of each antigen are also provided together with an extensive bibliography that allows a rapid search for any additional information may be needed on each single antigen or epitope. Overall, the updated list is a database tool for clinicians, scientists and students who have an interest in the field of tumor immunology and immunotherapy.

AB - The technological advances occurred in the last few years have led to a great increase in the number of tumor associated antigens (TAA) that are currently available for clinical applications. In this review we provide a comprehensive list of human tumor antigens as reported in the literature updated at Feburary 2004. The list includes all T cell-defined epitopes, while excluding analogs or artificially modified epitopes, as well as virus-encoded and antibodies-recognized antigens. TAAs are listed in alphabetical order along with the epitope sequence and the HLA allele which restricts recognition by T cells. Data on the tissue distribution of each antigen are also provided together with an extensive bibliography that allows a rapid search for any additional information may be needed on each single antigen or epitope. Overall, the updated list is a database tool for clinicians, scientists and students who have an interest in the field of tumor immunology and immunotherapy.

KW - Antigens

KW - Epitopes

KW - T cells

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=12944325331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944325331&partnerID=8YFLogxK

U2 - 10.1007/s00262-004-0560-6

DO - 10.1007/s00262-004-0560-6

M3 - Article

C2 - 15309328

AN - SCOPUS:12944325331

VL - 54

SP - 187

EP - 207

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 3

ER -